de State Street National Healthcare NHC Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 112 M | Comprar |
526,732
+35,157
| +7% | +USD 6.46 M | ﹤0.01% | 1430 |
|
|
2026
Q1 | USD 78.8 M | Comprar |
491,575
+6,525
| +1% | +USD 1 M | ﹤0.01% | 1507 |
|
|
2025
Q4 | USD 66.8 M | Vender |
485,050
-5,582
| -1% | -USD 721 k | ﹤0.01% | 1587 |
|
|
2025
Q3 | USD 59.9 M | Vender |
490,632
-2,033
| -0.4% | -USD 219 k | ﹤0.01% | 1631 |
|
|
2025
Q2 | USD 53 M | Vender |
492,665
-3,339
| -0.7% | -USD 334 k | ﹤0.01% | 1647 |
|
|
2025
Q1 | USD 46.3 M | Vender |
496,004
-10,945
| -2% | -USD 1.06 M | ﹤0.01% | 1686 |
|
|
2024
Q4 | USD 54.8 M | Comprar |
506,949
+12,737
| +3% | +USD 1.55 M | ﹤0.01% | 1670 |
|
|
2024
Q3 | USD 62.5 M | Vender |
494,212
-22,413
| -4% | -USD 2.82 M | ﹤0.01% | 1592 |
|
|
2024
Q2 | USD 56.3 M | Vender |
516,625
-19,992
| -4% | -USD 1.95 M | ﹤0.01% | 1613 |
|
|
2024
Q1 | USD 51 M | Comprar |
536,617
+5,598
| +1% | +USD 530 k | ﹤0.01% | 1719 |
|
|
2023
Q4 | USD 49.4 M | Comprar |
531,019
+205,955
| +63% | +USD 15.8 M | ﹤0.01% | 1708 |
|
|
2023
Q3 | USD 21 M | Vender |
325,064
-5,451
| -2% | -USD 349 k | ﹤0.01% | 2151 |
|
|
2023
Q2 | USD 20.6 M | Vender |
330,515
-33,133
| -9% | -USD 1.96 M | ﹤0.01% | 2232 |
|
|
2023
Q1 | USD 21.3 M | Comprar |
363,648
+13,032
| +4% | +USD 749 k | ﹤0.01% | 2181 |
|
|
2022
Q4 | USD 21.1 M | Comprar |
350,616
+7,737
| +2% | +USD 469 k | ﹤0.01% | 2208 |
|
|
2022
Q3 | USD 21.9 M | Comprar |
342,879
+5,317
| +2% | +USD 369 k | ﹤0.01% | 2149 |
|
|
2022
Q2 | USD 23.8 M | Comprar |
337,562
+9,621
| +3% | +USD 674 k | ﹤0.01% | 2132 |
|
|
2022
Q1 | USD 23.2 M | Comprar |
327,941
+7,583
| +2% | +USD 510 k | ﹤0.01% | 2287 |
|
|
2021
Q4 | USD 21.9 M | Comprar |
320,358
+871
| +0.3% | +USD 60.3 k | ﹤0.01% | 2418 |
|
|
2021
Q3 | USD 22.5 M | Comprar |
319,487
+9,653
| +3% | +USD 702 k | ﹤0.01% | 2394 |
|
|
2021
Q2 | USD 21.8 M | Comprar |
309,834
+15,519
| +5% | +USD 1.13 M | ﹤0.01% | 2452 |
|
|
2021
Q1 | USD 23.1 M | Comprar |
294,315
+2,190
| +0.7% | +USD 155 k | ﹤0.01% | 2279 |
|
|
2020
Q4 | USD 19.6 M | Vender |
292,125
-10,621
| -4% | -USD 700 k | ﹤0.01% | 2250 |
|
|
2020
Q3 | USD 19 M | Vender |
302,746
-36,247
| -11% | -USD 2.27 M | ﹤0.01% | 2068 |
|
|
2020
Q2 | USD 21.7 M | Comprar |
338,993
+7,161
| +2% | +USD 480 k | ﹤0.01% | 1989 |
|
|
2020
Q1 | USD 24 M | Comprar |
331,832
+1,227
| +0.4% | +USD 97.1 k | ﹤0.01% | 1736 |
|
|
2019
Q4 | USD 28.7 M | Comprar |
330,605
+929
| +0.3% | +USD 77.6 k | ﹤0.01% | 1890 |
|
|
2019
Q3 | USD 27.2 M | Comprar |
329,676
+2,183
| +0.7% | +USD 181 k | ﹤0.01% | 1860 |
|
|
2019
Q2 | USD 26.7 M | Comprar |
327,493
+19,841
| +6% | +USD 1.53 M | ﹤0.01% | 1910 |
|
|
2019
Q1 | USD 23.5 M | Vender |
307,652
-23,429
| -7% | -USD 1.86 M | ﹤0.01% | 1940 |
|
|
2018
Q4 | USD 26.1 M | Comprar |
331,081
+19,411
| +6% | +USD 1.52 M | ﹤0.01% | 1796 |
|
|
2018
Q3 | USD 23.5 M | Comprar |
311,670
+38,601
| +14% | +USD 2.84 M | ﹤0.01% | 2068 |
|
|
2018
Q2 | USD 19.2 M | Vender |
273,069
-8,764
| -3% | -USD 573 k | ﹤0.01% | 2156 |
|
|
2018
Q1 | USD 16.8 M | Vender |
281,833
-16,878
| -6% | -USD 1.03 M | ﹤0.01% | 2168 |
|
|
2017
Q4 | USD 18.2 M | Comprar |
298,711
+14,308
| +5% | +USD 913 k | ﹤0.01% | 2108 |
|
|
2017
Q3 | USD 17.8 M | Comprar |
284,403
+443
| +0.2% | +USD 28.5 k | ﹤0.01% | 2103 |
|
|
2017
Q2 | USD 19.9 M | Comprar |
283,960
+17,106
| +6% | +USD 1.22 M | ﹤0.01% | 1993 |
|
|
2017
Q1 | USD 19 M | Comprar |
266,854
+19,872
| +8% | +USD 1.47 M | ﹤0.01% | 1978 |
|
|
2016
Q4 | USD 18.7 M | Comprar |
246,982
+29,738
| +14% | +USD 2.06 M | ﹤0.01% | 1944 |
|
|
2016
Q3 | USD 14.3 M | Comprar |
217,244
+7,266
| +3% | +USD 472 k | ﹤0.01% | 1987 |
|
|
2016
Q2 | USD 13.6 M | Comprar |
209,978
+9,576
| +5% | +USD 608 k | ﹤0.01% | 2023 |
|
|
2016
Q1 | USD 12.5 M | Comprar |
200,402
+25,902
| +15% | +USD 1.61 M | ﹤0.01% | 2039 |
|
|
2015
Q4 | USD 10.8 M | Comprar |
174,500
+9,033
| +5% | +USD 585 k | ﹤0.01% | 2140 |
|
|
2015
Q3 | USD 10.1 M | Vender |
165,467
-3,348
| -2% | -USD 210 k | ﹤0.01% | 2182 |
|
|
2015
Q2 | USD 11 M | Comprar |
168,815
+1,853
| +1% | +USD 118 k | ﹤0.01% | 2207 |
|
|
2015
Q1 | USD 10.6 M | Comprar |
166,962
+1,206
| +0.7% | +USD 76.6 k | ﹤0.01% | 2186 |
|
|
2014
Q4 | USD 10.4 M | Vender |
165,756
-11,535
| -7% | -USD 693 k | ﹤0.01% | 2199 |
|
|
2014
Q3 | USD 9.8 M | Vender |
177,291
-3,998
| -2% | -USD 226 k | ﹤0.01% | 2194 |
|
|
2014
Q2 | USD 10.2 M | Vender |
181,289
-18,951
| -9% | -USD 1.03 M | ﹤0.01% | 2220 |
|
|
2014
Q1 | USD 11.2 M | Vender |
200,240
-3,164
| -2% | -USD 166 k | ﹤0.01% | 2148 |
|
|
2013
Q4 | USD 11 M | Comprar |
203,404
+1,172
| +0.6% | +USD 59.9 k | ﹤0.01% | 2139 |
|
|
2013
Q3 | USD 9.6 M | Vender |
202,232
-15,460
| -7% | -USD 739 k | ﹤0.01% | 2152 |
|
|
2013
Q2 | USD 10.4 M | Comprar |
+217,692
| Nuevas | +USD 10.2 M | ﹤0.01% | 2024 |
|
Otros fondos que tienen NHC en su cartera
Posición de State Street en NHC: resumen de T2 2026
State Street aumentó su participación en National Healthcare (NHC) en 7.2% durante T2 2026, al comprar aproximadamente USD 6.46 M y elevar la posición a 526,732 acciones con un valor de USD 112 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #1430.
State Street reportó por primera vez una posición en NHC en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. Al cierre de T2 2026, 248 fondos que sigue Wall St. Rank mantienen una posición en NHC.
- Al cierre de T2 2026, State Street tenía 526,732 acciones de National Healthcare con un valor de USD 112 M.
- State Street compró 35,157 acciones de National Healthcare en T2 2026, por un monto estimado de USD 6.46 M.
- National Healthcare representó ﹤0.01% de la cartera de State Street en T2 2026 y fue su posición número 1430.
- State Street reportó por primera vez una posición en National Healthcare en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- Al cierre de T2 2026, 248 fondos que sigue Wall St. Rank tenían National Healthcare en cartera.
Según el Informe 13F de State Street correspondiente a T2 2026, presentado el 7 ago 2026.